Anne-catherine C. Raby

Cardiff, WLS CF144XN, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification.

Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification.

Journal: Biomolecules

Published: April 16, 2026

Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics.

Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics.

Journal: Cells

Published: March 28, 2025

STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

Journal: The Journal of pathology

Published: January 31, 2025

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection.

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection.

Journal: Frontiers in cellular and infection microbiology

Published: August 29, 2023

Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology.

Therapeutic targeting of chronic kidney disease-associated DAMPs differentially contributing to vascular pathology.

Journal: Frontiers in immunology

Published: June 15, 2023

Wolf Rock lighthouse: past developments and future survivability under wave loading.

Wolf Rock lighthouse: past developments and future survivability under wave loading.

Journal: Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Published: August 20, 2019

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis.

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis.

Journal: Scientific reports

Published: April 26, 2019

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity.

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity.

Journal: Frontiers in physiology

Published: August 10, 2018

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.

Journal: Kidney international

Published: October 20, 2017

Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission.

Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission.

Journal: Intensive care medicine experimental

Published: November 02, 2016

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Journal: Journal of the American Society of Nephrology : JASN

Published: August 20, 2015

Therapeutic Boosting of the Immune Response: Turning to CD14 for Help.

Therapeutic Boosting of the Immune Response: Turning to CD14 for Help.

Journal: Current pharmaceutical biotechnology

Published: July 29, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026